The goal of this study is to determine the sensitivity, specificity, and positive and negative predictive values of the a portable near-infrared-based device (portable NIR-based device), the InfraScanner 2000â„¢, to detect intracranial hematomas (epidural hematomas (EDH) and/or subdural hematomas (SDH)) in patients hospitalized at Duke University Hospital (DUH) who have sustained or who are suspected to have sustained head trauma and have consequently received a brain computed tomography (CT) scan(s).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Sensitivity of InfraScanner 2000 TM to Detect Any Size Hematoma at the Patient Level
Timeframe: Up to 30 days after first CT scan
Sensitivity of InfraScanner 2000 TM to Detect Any Size Hematoma at the Scan Level
Timeframe: Up to 30 days after first CT scan
Specificity of InfraScanner 2000 TM for Detection of Any Size Hematoma at the Patient Level
Timeframe: Up to 30 days after first CT scan
Specificity of InfraScanner 2000 TM for Detection of Any Size Hematoma at the Scan Level
Timeframe: Up to 30 days after first CT scan
False Positive Rate of InfraScanner 2000 TM for Detection of Any Size Hematoma at the Patient Level
Timeframe: Up to 30 days after first CT scan
False Positive Rate of InfraScanner 2000 TM for Detection of Any Size Hematoma at the Scan Level
Timeframe: Up to 30 days after first CT scan
False Negative Rate of InfraScanner 2000 TM for Detection of Any Size Hematoma at the Patient Level
Timeframe: Up to 30 days after first CT scan
False Negative Rate of InfraScanner 2000 TM for Detection of Any Size Hematoma at the Scan Level
Timeframe: Up to 30 days after first CT scan